Taxanes are the most active drugs in the treatment of metastatic breast and ovarian cancer. Weekly therapy with paclitaxel produces notable activity, with remarkably low toxicity.
Henning Kühnle, MD
Advertisement
Articles by Henning Kühnle, MD
Advertisement
Latest Updated Articles
- UFT/Leucovorin Combined With Paclitaxel for Anthracycline-Pretreated Advanced Breast Cancer
Published: October 1st 2000 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Frontline Alectinib Upholds OS Benefit in Advanced ALK+ NSCLC
2
Episode 16: Anticipated ESMO 2025 Data That May Change GU Oncology
3
Lenvatinib/Everolimus Beats Cabozantinib in Phase 2 RCC Study
4
Exploring the ESMO 2025 Presentations That May Shift GU Oncology
5
